ALS has strategically partnered with NUVISAN to expand its client offering into research and development services whilst supplementing the ALS network with further GMP compliant QC laboratories. NUVISAN operates in both a contract research organisation (CRO) and a contract development and manufacturing organisation (CDMO) capacity providing drug testing services throughout the pharmaceutical development cycle. NUVISAN provides a unique opportunity for collaborators to consolidate almost all R&D activity to one provider. Broad capabilities, advanced technologies and dedicated Project Managers collectively drive real momentum throughout development transitions; ultimately increasing speed to patients.